Publication Results

Generate Report

Add publications by marking their checkboxes, or

Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Pinsky PF,  Miller EA,  Zhu CS,  Prorok PC
J Med Screen 2019 Sep;26(3):127-134
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 30943843
PMC ID: not available

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

Telomeres Mendelian Randomization Collaboration,  Haycock PC,  Burgess S,  Nounu A,  Zheng J,  Okoli GN,  Bowden J,  Wade KH,  Timpson NJ,  Evans DM,  Willeit P,  Aviv A,  Gaunt TR,  Hemani G,  Mangino M,  Ellis HP,  Kurian KM,  Pooley KA,  Eeles RA,  Lee JE,  Fang S,  Chen WV,  Law MH,  Bowdler LM,  Iles MM,  Yang Q,  Worrall BB,  Markus HS,  Hung RJ,  Amos CI,  Spurdle AB,  Thompson DJ,  O'Mara TA,  Wolpin B,  Amundadottir L,  Stolzenberg-Solomon R,  Trichopoulou A,  Onland-Moret NC,  Lund E,  Duell EJ,  Canzian F,  Severi G,  Overvad K,  Gunter MJ,  Tumino R,  Svenson U,  van Rij A,  Baas AF,  Bown MJ,  Samani NJ,  van t'Hof FNG,  Tromp G,  Jones GT,  Kuivaniemi H,  Elmore JR,  Johansson M,  Mckay J,  Scelo G,  Carreras-Torres R,  Gaborieau V,  Brennan P,  Bracci PM,  Neale RE,  Olson SH,  Gallinger S,  Li D,  Petersen GM,  Risch HA,  Klein AP,  Han J,  Abnet CC,  Freedman ND,  Taylor PR,  Maris JM,  Aben KK,  Kiemeney LA,  Vermeulen SH,  Wiencke JK,  Walsh KM,  Wrensch M,  Rice T,  Turnbull C,  Litchfield K,  Paternoster L,  Standl M,  Abecasis GR,  SanGiovanni JP,  Li Y,  Mijatovic V,  Sapkota Y,  Low SK,  Zondervan KT,  Montgomery GW,  Nyholt DR,  van Heel DA,  Hunt K,  Arking DE,  Ashar FN,  Sotoodehnia N,  Woo D,  Rosand J,  Comeau ME,  Brown WM,  Silverman EK,  Hokanson JE,  Cho MH,  Hui J,  Ferreira MA,  Thompson PJ,  Morrison AC,  Felix JF,  Smith NL,  Christiano AM,  Petukhova L,  Betz RC,  Fan X,  Zhang X,  Zhu C,  Langefeld CD,  Thompson SD,  Wang F,  Lin X,  Schwartz DA,  Fingerlin T,  Rotter JI,  Cotch MF,  Jensen RA,  Munz M,  Dommisch H,  Schaefer AS,  Han F,  Ollila HM,  Hillary RP,  Albagha O,  Ralston SH,  Zeng C,  Zheng W,  Shu XO,  Reis A,  Uebe S,  Hüffmeier U,  Kawamura Y,  Otowa T,  Sasaki T,  Hibberd ML,  Davila S,  Xie G,  Siminovitch K,  Bei JX,  Zeng YX,  Försti A,  Chen B,  Landi S,  Franke A,  Fischer A,  Ellinghaus D,  Flores C,  Noth I,  Ma SF,  Foo JN,  Liu J,  Kim JW,  Cox DG,  Delattre O,  Mirabeau O,  Skibola CF,  Tang CS,  Garcia-Barcelo M,  Chang KP,  Su WH,  Chang YS,  Martin NG,  Gordon S,  Wade TD,  Lee C,  Kubo M,  Cha PC,  Nakamura Y,  Levy D,  Kimura M,  Hwang SJ,  Hunt S,  Spector T,  Soranzo N,  Manichaikul AW,  Barr RG,  Kahali B,  Speliotes E,  Yerges-Armstrong LM,  Cheng CY,  Jonas JB,  Wong TY,  Fogh I,  Lin K,  Powell JF,  Rice K,  Relton CL,  Martin RM,  Davey Smith G
JAMA Oncol 2017 May 1;3(5):636-651
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 28241208
PMC ID: PMC5638008

Data sharing in clinical trials: An experience with two large cancer screening trials.

Zhu CS,  Pinsky PF,  Moler JE,  Kukwa A,  Mabie J,  Rathmell JM,  Riley T,  Prorok PC,  Berg CD
PLoS Med 2017 May;14(5):e1002304
Major Program(s) or Research Group(s): BiometryEarly Detection ;  Office of the Director
PubMed ID: 28542201
PMC ID: PMC5441574

The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.

Zhu CS,  Huang WY,  Pinsky PF,  Berg CD,  Sherman M,  Yu KJ,  Carrick DM,  Black A,  Hoover R,  Lenz P,  Williams C,  Hawkins L,  Chaloux M,  Yurgalevitch S,  Mathew S,  Miller A,  Olivo V,  Khan A,  Pretzel SM,  Multerer D,  Beckmann P,  Broski KG,  Freedman ND
Cancer Epidemiol Biomarkers Prev 2016 Dec;25(12):1635-1642
Major Program(s) or Research Group(s): Breast and Gynecologic CancerBiometryEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27635065
PMC ID: PMC5135604

Lung cancer risk by years since quitting in 30+ pack year smokers.

Pinsky PF,  Zhu CS,  Kramer BS
J Med Screen 2015 Sep;22(3):151-7
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 25926339
PMC ID: not available

The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.

Carrick DM,  Black A,  Gohagan JK,  Khan A,  Pettit K,  Williams C,  Yu K,  Yurgalevitch S,  Huang WY,  Zhu C
Rev Recent Clin Trials 2015;10(3):212-22
Major Program(s) or Research Group(s): BiometryEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 26238117
PMC ID: PMC6411281

Laboratory detective work identifies a mishandling problem in sample aliquoting.

Zhu C,  Pinsky P,  Huang WY,  Purdue M
Biopreserv Biobank 2014 Dec;12(6):430-2
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 25496156
PMC ID: PMC4275770

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS,  Pinsky PF,  Kramer BS,  Prorok PC,  Purdue MP,  Berg CD,  Gohagan JK
J Natl Cancer Inst 2013 Nov 20;105(22):1684-93
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 24115361
PMC ID: PMC3888207

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.

Pinsky PF,  Zhu C,  Skates SJ,  Black A,  Partridge E,  Buys SS,  Berg CD
Int J Cancer 2013 May 1;132(9):2127-33
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 23065684
PMC ID: not available

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE,  Pinsky PF,  Weissfeld JL,  Yokochi LA,  Church T,  Laiyemo AO,  Bresalier R,  Andriole GL,  Buys SS,  Crawford ED,  Fouad MN,  Isaacs C,  Johnson CC,  Reding DJ,  O'Brien B,  Carrick DM,  Wright P,  Riley TL,  Purdue MP,  Izmirlian G,  Kramer BS,  Miller AB,  Gohagan JK,  Prorok PC,  Berg CD,  PLCO Project Team
N Engl J Med 2012 Jun 21;366(25):2345-57
Major Program(s) or Research Group(s): BiometryProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 22612596
PMC ID: PMC3641846

The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.

Xie G,  Nie T,  Mackenzie GG,  Sun Y,  Huang L,  Ouyang N,  Alston N,  Zhu C,  Murray OT,  Constantinides PP,  Kopelovich L,  Rigas B
Br J Pharmacol 2012 Apr;165(7):2152-66
Major Program(s) or Research Group(s): Chemopreventive Agent Development
PubMed ID: 21955327
PMC ID: PMC3413853

Biospecimen reporting for improved study quality (BRISQ).

Moore HM,  Kelly AB,  Jewell SD,  McShane LM,  Clark DP,  Greenspan R,  Hayes DF,  Hainaut P,  Kim P,  Mansfield E,  Potapova O,  Riegman P,  Rubinstein Y,  Seijo E,  Somiari S,  Watson P,  Weier HU,  Zhu C,  Vaught J
J Proteome Res 2011 Aug 5;10(8):3429-38
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 21574648
PMC ID: PMC3169291

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS,  Partridge E,  Black A,  Johnson CC,  Lamerato L,  Isaacs C,  Reding DJ,  Greenlee RT,  Yokochi LA,  Kessel B,  Crawford ED,  Church TR,  Andriole GL,  Weissfeld JL,  Fouad MN,  Chia D,  O'Brien B,  Ragard LR,  Clapp JD,  Rathmell JM,  Riley TL,  Hartge P,  Pinsky PF,  Zhu CS,  Izmirlian G,  Kramer BS,  Miller AB,  Xu JL,  Prorok PC,  Gohagan JK,  Berg CD,  PLCO Project Team
JAMA 2011 Jun 8;305(22):2295-303
Major Program(s) or Research Group(s): Early DetectionBiometryProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21642681
PMC ID: not available

Biospecimen reporting for improved study quality (BRISQ).

Moore HM,  Kelly AB,  Jewell SD,  McShane LM,  Clark DP,  Greenspan R,  Hayes DF,  Hainaut P,  Kim P,  Mansfield EA,  Potapova O,  Riegman P,  Rubinstein Y,  Seijo E,  Somiari S,  Watson P,  Weier HU,  Zhu C,  Vaught J
Cancer Cytopathol 2011 Apr 25;119(2):92-101
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 21433001
PMC ID: not available

Biospecimen Reporting for Improved Study Quality.

Moore HM,  Kelly A,  Jewell SD,  McShane LM,  Clark DP,  Greenspan R,  Hainaut P,  Hayes DF,  Kim P,  Mansfield E,  Potapova O,  Riegman P,  Rubinstein Y,  Seijo E,  Somiari S,  Watson P,  Weier HU,  Zhu C,  Vaught J
Biopreserv Biobank 2011 Apr;9(1):57-70
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 21826252
PMC ID: PMC3142856

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Cramer DW,  Bast RC Jr,  Berg CD,  Diamandis EP,  Godwin AK,  Hartge P,  Lokshin AE,  Lu KH,  McIntosh MW,  Mor G,  Patriotis C,  Pinsky PF,  Thornquist MD,  Scholler N,  Skates SJ,  Sluss PM,  Srivastava S,  Ward DC,  Zhang Z,  Zhu CS,  Urban N
Cancer Prev Res (Phila) 2011 Mar;4(3):365-74
Major Program(s) or Research Group(s): Early DetectionCancer BiomarkersProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21372036
PMC ID: PMC3085251

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Zhu CS,  Pinsky PF,  Cramer DW,  Ransohoff DF,  Hartge P,  Pfeiffer RM,  Urban N,  Mor G,  Bast RC Jr,  Moore LE,  Lokshin AE,  McIntosh MW,  Skates SJ,  Vitonis A,  Zhang Z,  Ward DC,  Symanowski JT,  Lomakin A,  Fung ET,  Sluss PM,  Scholler N,  Lu KH,  Marrangoni AM,  Patriotis C,  Srivastava S,  Buys SS,  Berg CD,  PLCO Project Team
Cancer Prev Res (Phila) 2011 Mar;4(3):375-83
Major Program(s) or Research Group(s): Early DetectionCancer BiomarkersBiometryProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21372037
PMC ID: PMC3057372

Building multi-marker algorithms for disease prediction-the role of correlations among markers.

Pinsky PF,  Zhu CS
Biomark Insights 2011;6:83-93
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21918599
PMC ID: PMC3169344

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL,  Crawford ED,  Grubb RL 3rd,  Buys SS,  Chia D,  Church TR,  Fouad MN,  Gelmann EP,  Kvale PA,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Clapp JD,  Rathmell JM,  Riley TL,  Hayes RB,  Kramer BS,  Izmirlian G,  Miller AB,  Pinsky PF,  Prorok PC,  Gohagan JK,  Berg CD,  PLCO Project Team
N Engl J Med 2009 Mar 26;360(13):1310-9
Major Program(s) or Research Group(s): Early DetectionBiometryProstate, Lung, Colorectal, and Ovarian Cancer Screening TrialChemopreventive Agent Development
PubMed ID: 19297565
PMC ID: PMC2944770